XML 43 R31.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Fair Value Measurement (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Fair Value Disclosures [Abstract] |
Summary of assets and liabilities measured at fair value on recurring basis | The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis by the above fair value hierarchy levels as of September 30, 2022:
(Dollars in millions) | Level I |  | Level II |  | Level III |  | Total
Assets |  |  |  |  |  |  |
Investments of Consolidated Funds: |  |  |  |  |  |  |
Equity securities(1) | $ | — |  |  | $ | — |  |  | $ | 511.9 |  |  | $ | 511.9 |
Bonds | — |  |  | — |  |  | 560.8 |  |  | 560.8 |
Loans | — |  |  | — |  |  | 5,054.7 |  |  | 5,054.7 |
| — |  |  | — |  |  | 6,127.4 |  |  | 6,127.4 |
Investments in CLOs and other: |  |  |  |  |  |  |
Investments in CLOs | — |  |  | — |  |  | 499.6 |  |  | 499.6 |
Other investments(2) | 1.3 |  |  | 41.7 |  |  | 64.6 |  |  | 107.6 |
| 1.3 |  |  | 41.7 |  |  | 564.2 |  |  | 607.2 |
Corporate treasury investments |  |  |  |  |  |  |
Commercial paper and other | — |  |  | 69.5 |  |  | — |  |  | 69.5 |
Subtotal | $ | 1.3 |  |  | $ | 111.2 |  |  | $ | 6,691.6 |  |  | $ | 6,804.1 |
Investments measured at net asset value(3) |  |  |  |  |  |  | 294.6 |
Total |  |  |  |  |  |  | $ | 7,098.7 |
Liabilities |  |  |  |  |  |  |
Loans payable of Consolidated Funds(4) | $ | — |  |  | $ | — |  |  | $ | 5,303.7 |  |  | $ | 5,303.7 |
Foreign currency forward contracts | — |  |  | 29.5 |  |  | — |  |  | 29.5 |
Total(5) | $ | — |  |  | $ | 29.5 |  |  | $ | 5,303.7 |  |  | $ | 5,333.2 |
(1)This balance includes $453.4 million related to investments that have been bridged by the Company to investment funds that are actively fundraising and are accounted for as consolidated VIEs as of September 30, 2022. (2)The Level III balance excludes a $54.9 million corporate investment in equity securities which the Company has elected to account for under the measurement alternative for equity securities without readily determinable fair values pursuant to ASC 321, Investments – Equity Securities. As a non-recurring fair value measurement, the fair value of these equity securities is excluded from the tabular Level III rollforward disclosures. (3)Balance represents Fund Investments that the Company reports based on the most recent available information which typically has a lag of up to 90 days, of which $282.3 million relates to investments of Consolidated Funds. (4)Senior and subordinated notes issued by CLO vehicles are valued based on the more observable fair value of the CLO financial assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that represent compensation for services. (5)Total liabilities balance excludes $160.5 million of senior notes measured at cost and a $52.7 million revolving credit balance, both related to loans payable of Consolidated Funds. The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis by the above fair value hierarchy levels as of December 31, 2021:
(Dollars in millions) | Level I |  | Level II |  | Level III |  | Total
Assets |  |  |  |  |  |  |
Investments of Consolidated Funds: |  |  |  |  |  |  |
Equity securities | $ | — |  |  | $ | — |  |  | $ | 17.9 |  |  | $ | 17.9 |
Bonds | — |  |  | — |  |  | 599.5 |  |  | 599.5 |
Loans | — |  |  | — |  |  | 5,898.1 |  |  | 5,898.1 |
| — |  |  | — |  |  | 6,515.5 |  |  | 6,515.5 |
Investments in CLOs | — |  |  | — |  |  | 361.1 |  |  | 361.1 |
Other investments(1) | 1.5 |  |  | 45.6 |  |  | 78.7 |  |  | 125.8 |
Foreign currency forward contracts | — |  |  | 1.4 |  |  | — |  |  | 1.4 |
Subtotal | $ | 1.5 |  |  | $ | 47.0 |  |  | $ | 6,955.3 |  |  | $ | 7,003.8 |
Investments measured at net asset value(2) |  |  |  |  |  |  | 161.7 |
Total |  |  |  |  |  |  | $ | 7,165.5 |
Liabilities |  |  |  |  |  |  |
Loans payable of Consolidated Funds(3) | $ | — |  |  | $ | — |  |  | $ | 5,811.0 |  |  | $ | 5,811.0 |
Foreign currency forward contracts | — |  |  | 0.7 |  |  | — |  |  | 0.7 |
Total(4) | $ | — |  |  | $ | 0.7 |  |  | $ | 5,811.0 |  |  | $ | 5,811.7 |
(1)The Level III balance excludes a corporate investment in equity securities which the Company has elected to account for under the measurement alternative for equity securities without readily determinable fair values pursuant to ASC 321, Investments – Equity Securities. In December 2021, the Company remeasured this investment to a fair value of $54.9 million due to an observable price change. As a non-recurring fair value measurement, the fair value of these equity securities is excluded from the tabular Level III rollforward disclosures. (2)Balance represents Fund Investments that the Company reports based on the most recent available information which typically has a lag of up to 90 days, of which $145.5 million relates to investments of Consolidated Funds. (3)Senior and subordinated notes issued by CLO vehicles are valued based on the more observable fair value of the CLO financial assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that represent compensation for services. (4)Total liabilities balance excludes a $79.0 million revolving credit balance related to loans payable of Consolidated Funds.
Changes in Level III financial assets measured at fair value | The changes in financial instruments measured at fair value for which the Company has used Level III inputs to determine fair value are as follows (Dollars in millions):
| Financial Assets
| Three Months Ended September 30, 2022
| Investments of Consolidated Funds |  |  |  |  |  |
| Equity securities |  | Bonds |  | Loans |  |  |  |  |  | Investments in CLOs |  | Other investments |  | Total
Balance, beginning of period | $ | 12.4 |  |  | $ | 669.8 |  |  | $ | 5,516.8 |  |  |  |  |  |  | $ | 508.6 |  |  | $ | 65.1 |  |  | $ | 6,772.7 |
Purchases | 518.5 |  |  | 46.6 |  |  | 473.9 |  |  |  |  |  |  | 19.9 |  |  | — |  |  | 1,058.9 |
Sales and distributions | — |  |  | (92.6) |  |  | (552.4) |  |  |  |  |  |  | (7.2) |  |  | (0.9) |  |  | (653.1) |
Settlements | — |  |  | — |  |  | (130.4) |  |  |  |  |  |  | — |  |  | — |  |  | (130.4) |
Realized and unrealized gains (losses), net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Included in earnings | (18.3) |  |  | (21.6) |  |  | (30.0) |  |  |  |  |  |  | 7.1 |  |  | 0.4 |  |  | (62.4) |
Included in other comprehensive income | (0.7) |  |  | (41.4) |  |  | (223.2) |  |  |  |  |  |  | (28.8) |  |  | — |  |  | (294.1) |
Balance, end of period | $ | 511.9 |  |  | $ | 560.8 |  |  | $ | 5,054.7 |  |  |  |  |  |  | $ | 499.6 |  |  | $ | 64.6 |  |  | $ | 6,691.6 |
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date | $ | (18.3) |  |  | $ | (22.1) |  |  | $ | (35.7) |  |  |  |  |  |  | $ | 4.5 |  |  | $ | 0.4 |  |  | $ | (71.2) |
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date | $ | (0.7) |  |  | $ | (34.3) |  |  | $ | (202.2) |  |  |  |  |  |  | $ | (28.8) |  |  | $ | — |  |  | $ | (266.0) |
| Financial Assets
| Nine Months Ended September 30, 2022
| Investments of Consolidated Funds |  |  |  |  |  |
| Equity securities |  | Bonds |  | Loans |  |  |  |  |  | Investments in CLOs |  | Other investments | Total
Balance, beginning of period | $ | 17.9 |  |  | $ | 599.5 |  |  | $ | 5,898.1 |  |  |  |  |  |  | $ | 361.1 |  |  | $ | 78.7 |  |  | $ | 6,955.3 |
Purchases | 518.6 |  |  | 429.0 |  |  | 2,014.8 |  |  |  |  |  |  | 251.9 |  |  | 0.9 |  |  | 3,215.2 |
Sales and distributions | (7.2) |  |  | (320.2) |  |  | (1,566.5) |  |  |  |  |  |  | (36.1) |  |  | (3.8) |  |  | (1,933.8) |
Settlements | — |  |  | (0.3) |  |  | (492.1) |  |  |  |  |  |  | — |  |  | — |  |  | (492.4) |
Realized and unrealized gains (losses), net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Included in earnings | (15.9) |  |  | (59.6) |  |  | (277.4) |  |  |  |  |  |  | (17.9) |  |  | (11.2) |  |  | (382.0) |
Included in other comprehensive income | (1.5) |  |  | (87.6) |  |  | (522.2) |  |  |  |  |  |  | (59.4) |  |  | — |  |  | (670.7) |
Balance, end of period | $ | 511.9 |  |  | $ | 560.8 |  |  | $ | 5,054.7 |  |  |  |  |  |  | $ | 499.6 |  |  | $ | 64.6 |  |  | $ | 6,691.6 |
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date | $ | (16.7) |  |  | $ | (57.0) |  |  | $ | (266.3) |  |  |  |  |  |  | $ | (17.9) |  |  | $ | (11.2) |  |  | $ | (369.1) |
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date | $ | (1.3) |  |  | $ | (55.2) |  |  | $ | (422.7) |  |  |  |  |  |  | $ | (59.4) |  |  | $ | — |  |  | $ | (538.6) |
| Financial Assets
| Three Months Ended September 30, 2021
| Investments of Consolidated Funds |  |  |  |  |  |
| Equity securities |  | Bonds |  | Loans |  |  |  |  |  | Investments in CLOs |  | Other investments |  | Total
Balance, beginning of period | $ | 18.3 |  |  | $ | 542.0 |  |  | $ | 5,543.6 |  |  |  |  |  |  | $ | 353.1 |  |  | $ | 78.4 |  |  | $ | 6,535.4 |
Consolidation of funds (1) | 3.3 |  |  | — |  |  | 490.4 |  |  |  |  |  |  | (3.0) |  |  | — |  |  | 490.7 |
Purchases | 0.1 |  |  | 108.1 |  |  | 1,058.4 |  |  |  |  |  |  | 9.6 |  |  | — |  |  | 1,176.2 |
Sales and distributions | (1.2) |  |  | (44.0) |  |  | (781.0) |  |  |  |  |  |  | (14.5) |  |  | (0.4) |  |  | (841.1) |
Settlements | — |  |  | (0.2) |  |  | (378.4) |  |  |  |  |  |  | — |  |  | — |  |  | (378.6) |
Realized and unrealized gains (losses), net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Included in earnings | (1.3) |  |  | (11.3) |  |  | 13.3 |  |  |  |  |  |  | 6.2 |  |  | 0.7 |  |  | 7.6 |
Included in other comprehensive income | (0.3) |  |  | (13.5) |  |  | (93.4) |  |  |  |  |  |  | (6.7) |  |  | — |  |  | (113.9) |
Balance, end of period | $ | 18.9 |  |  | $ | 581.1 |  |  | $ | 5,852.9 |  |  |  |  |  |  | $ | 344.7 |  |  | $ | 78.7 |  |  | $ | 6,876.3 |
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date | $ | (1.9) |  |  | $ | 1.5 |  |  | $ | (4.2) |  |  |  |  |  |  | $ | 6.2 |  |  | $ | 1.1 |  |  | $ | 2.7 |
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date | $ | (0.3) |  |  | $ | (13.7) |  |  | $ | (92.3) |  |  |  |  |  |  | $ | (6.7) |  |  | $ | — |  |  | $ | (113.0) |
| Financial Assets
| Nine Months Ended September 30, 2021
| Investments of Consolidated Funds |  |  |  |  |  |
| Equity securities |  | Bonds |  | Loans |  |  |  |  |  | Investments in CLOs |  | Other investments(2) |  | Total
Balance, beginning of period | $ | 9.4 |  |  | $ | 550.4 |  |  | $ | 5,497.1 |  |  |  |  |  |  | $ | 489.4 |  |  | $ | 81.4 |  |  | $ | 6,627.7 |
Deconsolidation/consolidation of funds (1) | 5.7 |  |  | — |  |  | 314.2 |  |  |  |  |  |  | 23.1 |  |  | — |  |  | 343.0 |
Purchases | 0.6 |  |  | 472.0 |  |  | 3,375.3 |  |  |  |  |  |  | 71.7 |  |  | — |  |  | 3,919.6 |
Sales and distributions | (3.5) |  |  | (405.2) |  |  | (2,199.0) |  |  |  |  |  |  | (238.4) |  |  | (16.5) |  |  | (2,862.6) |
Settlements | — |  |  | (3.8) |  |  | (1,020.2) |  |  |  |  |  |  | — |  |  | — |  |  | (1,024.0) |
Realized and unrealized gains (losses), net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Included in earnings | 7.3 |  |  | (1.3) |  |  | 103.1 |  |  |  |  |  |  | 2.7 |  |  | 13.8 |  |  | 125.6 |
Included in other comprehensive income | (0.6) |  |  | (31.0) |  |  | (217.6) |  |  |  |  |  |  | (3.8) |  |  | — |  |  | (253.0) |
Balance, end of period | $ | 18.9 |  |  | $ | 581.1 |  |  | $ | 5,852.9 |  |  |  |  |  |  | $ | 344.7 |  |  | $ | 78.7 |  |  | $ | 6,876.3 |
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date | $ | 5.2 |  |  | $ | 7.7 |  |  | $ | 61.1 |  |  |  |  |  |  | $ | 2.3 |  |  | $ | 14.0 |  |  | $ | 90.3 |
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date | $ | (0.4) |  |  | $ | (22.0) |  |  | $ | (185.3) |  |  |  |  |  |  | $ | (3.8) |  |  | $ | — |  |  | $ | (211.5) |
(1) As a result of the consolidation of one CLO during the three months ended September 30, 2021 and two CLOs during the nine months ended September 30, 2021, the investments that the Company held in those CLOs are now eliminated in consolidation and no longer included in investments in CLOs and other. As a result of the deconsolidation of one CLO during the nine months ended September 30, 2021, the investment that the Company held in that CLO is no longer eliminated in consolidation and is now included in investments in CLOs and other. (2) The beginning balance of Other Investments has been revised to reflect the exclusion of Fund Investments measured at fair value using the NAV per share practical expedient from the fair value hierarchy.
Changes in Level III financial liabilities measured at fair value |
| Financial Liabilities
| Loans Payable of Consolidated Funds
| Three Months Ended September 30,
| 2022 |  | 2021
Balance, beginning of period | $ | 5,757.8 |  |  | $ | 5,373.9 |
Consolidation of funds | — |  |  | 480.0 |
Borrowings | 26.4 |  |  | 1,133.0 |
Paydowns | (1.8) |  |  | (712.0) |
Sales | (193.9) |  |  | (237.5) |
Realized and unrealized (gains) losses, net |  |  |
Included in earnings | (40.8) |  |  | (2.4) |
Included in other comprehensive income | (244.0) |  |  | (96.7) |
Balance, end of period | $ | 5,303.7 |  |  | $ | 5,938.3 |
Changes in unrealized (gains) losses included in earnings related to financial liabilities still held at the reporting date | $ | (41.3) |  |  | $ | 3.7 |
Changes in unrealized (gains) losses included in other comprehensive income related to financial liabilities still held at the reporting date | $ | (235.5) |  |  | $ | (127.0) |
| Financial Liabilities
| Loans Payable of Consolidated Funds
| Nine Months Ended September 30,
| 2022 |  | 2021
Balance, beginning of period | $ | 5,811.0 |  |  | $ | 5,563.0 |
Deconsolidation/consolidation of funds | — |  |  | 360.8 |
Borrowings | 1,597.7 |  |  | 1,966.6 |
Paydowns | (419.1) |  |  | (1,303.0) |
Sales | (863.4) |  |  | (515.2) |
Realized and unrealized (gains) losses, net |  |  |
Included in earnings | (268.3) |  |  | 90.7 |
Included in other comprehensive income | (554.2) |  |  | (224.6) |
Balance, end of period | $ | 5,303.7 |  |  | $ | 5,938.3 |
Changes in unrealized (gains) losses included in earnings related to financial liabilities still held at the reporting date | $ | (262.6) |  |  | $ | 98.1 |
Changes in unrealized (gains) losses included in other comprehensive income related to financial liabilities still held at the reporting date | $ | (567.0) |  |  | $ | (281.4) |
Summary of quantitative information about Level III inputs | The following table summarizes quantitative information about the Company’s Level III inputs as of September 30, 2022:
| Fair Value at |  | Valuation Technique(s) |  | Unobservable Input(s) |  | Range (Weighted Average)
(Dollars in millions) | September 30, 2022 |  |  |
Assets |  |  |  |  |  |  |
Investments of Consolidated Funds: |  |  |  |  |  |  |
Equity securities | $ | 10.4 |  |  | Consensus Pricing |  | Indicative Quotes ($ per share) |  | 0.00 - 17.00 (0.43)
| 445.2 |  |  | Discounted Cash Flow |  | Discount Rates |  | 9% - 10% (9%)
| 56.3 |  |  | Other (1) |  | N/A |  | N/A
Bonds | 560.8 |  |  | Consensus Pricing |  | Indicative Quotes (% of Par) |  | 55 - 125 (89)
Loans | 4,853.1 |  |  | Consensus Pricing |  | Indicative Quotes (% of Par) |  | 0 - 103 (93)
| 24.0 |  |  | Discounted Cash Flow |  | Discount Rates |  | 9% - 12% (10%)
| 116.3 |  |  | Discounted Cash Flow |  | Discount Rates |  | 7% - 10% (8%)
| 61.3 |  |  | Consensus Pricing |  | Indicative Quotes (% of Par) |  | 98% -98% (98%)
| 6,127.4 |  |  |  |  |  |  |
Investments in CLOs: |  |  |  |  |  |  |
Senior secured notes | 430.7 |  |  | Consensus Pricing with Discounted Cash Flow |  | Indicative Quotes (% of Par) |  | 74 - 100 (95)
|  |  |  |  | Discount Margins (Basis Points) |  | 155 - 1,700 (336)
|  |  |  |  | Default Rates |  | 1% - 3% (2%)
|  |  |  |  | Recovery Rates |  | 50% - 70% (60%)
Subordinated notes and preferred shares | 68.9 |  |  | Consensus Pricing with Discounted Cash Flow |  | Indicative Quotes (% of Par) |  | 21 - 66 (49)
|  |  |  |  | Discount Rates |  | 13% - 25% (19%)
|  |  |  |  | Default Rates |  | 1% - 3% (2%)
|  |  |  |  | Recovery Rates |  | 50% - 70% (60%)
Other investments: |  |  |  |  |  |  |
BDC preferred shares | 61.2 |  |  | Market Yield Analysis |  | Market Yield |  | 7% - 7% (7%)
Aviation subordinated notes | 3.4 |  |  | Discounted Cash Flow |  | Discount Rates |  | 22% - 22% (22%)
Total | $ | 6,691.6 |  |  |  |  |  |  |
Liabilities |  |  |  |  |  |  |
Loans payable of Consolidated Funds: |  |  |  |  |  |  |
Senior secured notes | $ | 5,085.8 |  |  | Other (2) |  | N/A |  | N/A
Subordinated notes and preferred shares | 217.9 |  |  | Consensus Pricing with Discounted Cash Flow |  | Indicative Quotes (% of Par) |  | 19 - 103 (43)
|  |  |  |  | Discount Rates |  | 15% - 25% (20%)
|  |  |  |  | Default Rates |  | 2% - 3% (2%)
|  |  |  |  | Recovery Rates |  | 50% - 70% (60%)
Total | $ | 5,303.7 |  |  |  |  |  |  |
(1) Fair value approximates transaction price that was in close proximity to the reporting date. (2) Senior and subordinated notes issued by CLO vehicles are classified based on the more observable fair value of the CLO financial assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that represent compensation for services. The following table summarizes quantitative information about the Company’s Level III inputs as of December 31, 2021:
| Fair Value at |  | Valuation Technique(s) |  | Unobservable Input(s) |  | Range (Weighted Average)
(Dollars in millions) | December 31, 2021 |  |  |
Assets |  |  |  |  |  |  |
Investments of Consolidated Funds: |  |  |  |  |  |  |
Equity securities | $ | 17.9 |  |  | Consensus Pricing |  | Indicative Quotes ($ per share) |  | 0.00 - 84.22 (0.63)
Bonds | 599.5 |  |  | Consensus Pricing |  | Indicative Quotes (% of Par) |  | 93 - 107 (99)
Loans | 5,766.0 |  |  | Consensus Pricing |  | Indicative Quotes (% of Par) |  | 35 - 106 (98)
| 65.1 |  |  | Discounted Cash Flow |  | Discount Rates |  | 4% - 8% (5%)
| 67.0 |  |  | Market Yield Analysis |  | Market Yields |  | 3% - 8% (5%)
| 6,515.5 |  |  |  |  |  |  |
Investments in CLOs: |  |  |  |  |  |  |
Senior secured notes | 289.7 |  |  | Discounted Cash Flow with Consensus Pricing |  | Indicative Quotes (% of Par) |  | 86 - 101 (99)
|  |  |  |  | Discount Margins (Basis Points) |  | 50 - 1,330 (245)
|  |  |  |  | Default Rates |  | 1% - 2% (1%)
|  |  |  |  | Recovery Rates |  | 50% - 70% (60%)
Subordinated notes and preferred shares | 71.5 |  |  | Discounted Cash Flow with Consensus Pricing |  | Indicative Quotes (% of Par) |  | 46 - 97 (63)
|  |  |  |  | Discount Rate |  | 14% - 22% (19%)
|  |  |  |  | Default Rates |  | 1% - 2% (1%)
|  |  |  |  | Recovery Rates |  | 50% - 70% (60%)
Other investments: |  |  |  |  |  |  |
BDC preferred shares | 72.5 |  |  | Market Yield Analysis |  | Market Yield |  | 7% - 7% (7%)
Aviation subordinated notes | 6.1 |  |  | Discounted Cash Flow |  | Discount Rates |  | 18% - 18% (18%)
Total | $ | 6,955.3 |  |  |  |  |  |  |
Liabilities |  |  |  |  |  |  |
Loans payable of Consolidated Funds: |  |  |  |  |  |  |
Senior secured notes | $ | 5,561.1 |  |  | Other (1) |  | N/A |  | N/A
Subordinated notes and preferred shares | 249.9 |  |  | Discounted Cash Flow with Consensus Pricing |  | Indicative Quotes (% of Par) |  | 40 - 97 (61)
|  |  |  |  | Discount Rates |  | 14% - 22% (19%)
|  |  |  |  | Default Rates |  | 1% - 2% (1%)
|  |  |  |  | Recovery Rates |  | 50% - 70% (60%)
Total | $ | 5,811.0 |  |  |  |  |  |  |
(1) Senior and subordinated notes issued by CLO vehicles are classified based on the more observable fair value of the CLO financial assets, less (i) the fair value of any beneficial interests held by the Company and (ii) the carrying value of any beneficial interests that represent compensation for services.

X
- Definition Schedule of quantitative information about partnership level three inputs. + References No definition available. + Details
Name: | cg_ScheduleOfQuantitativeInformationAboutPartnershipLevelThreeInputsTableTableTextBlock
Namespace Prefix: | cg_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration